Home › Funds › Ikarian Capital, LLC › ANIP
Ikarian Capital, LLC position in ANIP
ANI PHARMACEUTICALS INC · Health Care
Ikarian Capital, LLC reported holding 272,085 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$22.5M, representing 3.62% of its reported portfolio and ranking #6 among its reported holdings. Ikarian Capital, LLC has disclosed ANIP holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's ANIP position evolved
Ikarian Capital, LLC first disclosed a stake in ANIP in Q4 2025 at 82,800 shares (US$6.5M). The position peaked in Q2 2026 at 272,085 shares, worth US$22.5M. Across 3 filings, Ikarian Capital, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 272,085 shares valued at US$22.5M — an increase of 125,000 shares quarter over quarter.. Notable position changes include a 78% increase in Q1 2026 (shares rose 8% over the following quarter), a 85% increase in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 82.80K | $6.54M | New |
| Q1 2026 | 147.09K | $11.31M | Add |
| Q2 2026 | 272.08K | $22.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIP and 13F data
ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIP
- Soleus Capital Management, L.P. 867.76K sh · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K sh · $58.57M · Q2 2026
- Global Alpha Capital Management Ltd. 558.00K sh · $46.19M · Q2 2026
- Empyrean Capital Partners, LP 23.00M sh · $29.75M · Q2 2026
- Ranger Investment Management, L.P. 343.15K sh · $28.41M · Q2 2026
- HBK INVESTMENTS L P 20.15M sh · $26.12M · Q2 2026
- Jones Hill Capital LP 233.81K sh · $19.35M · Q2 2026
- Penn Capital Management Company, LLC 207.36K sh · $17.18M · Q2 2026
- BOUSSARD & GAVAUDAN GESTION SAS 13.00K sh · $17.07M · Q2 2026
- Parkman Healthcare Partners LLC 202.91K sh · $16.80M · Q2 2026
- Boussard & Gavaudan Investment Management LLP 13.35K sh · $16.46M · Q1 2026
- ABSOLUTE INVESTMENT ADVISERS, LLC 11.72M sh · $15.17M · Q2 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held ANIP?
Ikarian Capital, LLC has disclosed ANIP holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Ikarian Capital, LLC's current position in ANIP?
As of Q2 2026, Ikarian Capital, LLC holds 272.08K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $22.52M, representing 3.62% of its reported portfolio and ranking #6.
Has Ikarian Capital, LLC been buying or selling ANIP?
In the latest 13F filing (Q2 2026), Ikarian Capital, LLC increased its position in ANIP. The position peaked in Q2 2026 at 272.08K shares.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.